Home
Search
Human Health

Vaccines & Biodefense

In the U.S., the recommended immunization series prevents approximately 33,000 deaths each year. Advancements in biotechnology have made it possible to produce vaccines that cannot transmit a virus or bacterium. This method has helped create more than 20 new vaccines against infectious agents, improved existing vaccines, and increased the amount of vaccine that can be produced.

Coronavirus
Biotech Response to COVID-19

As the threat of the novel coronavirus continues to grow globally, innovative biopharmaceutical companies are ramping up efforts to study the virus and develop vaccines and cures to protect individuals from contracting the virus.

Learn More
Blog Posts
Browse all Blogs
Vaccine
How you can help #FlattenTheFlu
November 20, 2020
Even in a global pandemic, there’s one thing that hasn’t changed: the need to get a flu shot. In fact, receiving a flu shot is more important than ever to avoid burdening the hospitals and health care professionals…
HIV Test
Coordinating Care for People Living and Aging with HIV
September 29, 2020
  Today, more than 50% of all people living with HIV in the United States are over the age of 50. Ten years from now that percentage is estimated to go up to 70% and more than four in five people…
Patient & Health Advocacy Summit Digital
A Unique Conference for a Unique Year
September 23, 2020
This year has feels like an unfair pile on. One crisis follows another while the first never gets resolved. From the pandemic to global recession to civil unrest to raging fires to hurricanes, the relentless onslaught…
Press Releases
Browse all Press Releases
BIO’s Dr. Michelle McMurry-Heath Congratulates President-Elect Biden & Other Newly Elected Leaders of Both Parties Who Won
November 7, 2020
"What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records.    "At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes 2020, and while we certainly did not pick sides or…
Gov. Hogan, Novavax’ Erck, & BIO’s Dr. McMurry-Heath Toured Novavax Labs and Discussed Progress on COVID-19 Vaccine
September 24, 2020
Event Highlighted Leadership in Vaccine Development and Regional Growth in Biotechnology Innovation Gaithersburg, MD (September 24, 2020) – Today, Maryland Governor Larry Hogan and Dr. Michelle McMurry-Heath, President & CEO of Biotechnology Innovation Organization (BIO), joined Novavax…
BIO Elects New Board Directors and Section Governing Board Chairs
June 16, 2020
The Biotechnology Innovation Organization (BIO) is pleased to announce the election of its new Executive Committee members for the 2020-2021 term. Additionally, eight new board directors and four new section governing board chairs and vice chairs were elected. BIO’s Board elections took place…
Letters, Comments & Testimony
Browse all Letters, Comments & Testimony
BIO Comments on FDA Draft Guidance, Drug-Drug Interaction Assessment for Therapeutic Proteins
November 9, 2020
On November 9, BIO submitted comments on the FDA Draft Guidance, Drug-Drug Interaction Assessment for Therapeutic Proteins. In the comments, BIO thanks the FDA for the opportunity to submit comments but requests that the Guidance include a discussion on the potential of generalizing information…
Patient Reported Outcomes: BIO Comments on FDA Draft Guidance Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation
October 30, 2020
October 30, 2020 Re: Docket No. FDA–2020-D-1564: FDA Draft Guidance, Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation. Dear Sir/Madam: The Biotechnology Innovation Organization (BIO) thanks the Food and Drug…
Right to Try: BIO Comments on Annual Summary Reporting Requirements Under the Right to Try Act, Proposed Rule
September 28, 2020
September 22, 2020 Re: Docket No. FDA-2019-N-5553: Annual Summary Reporting Requirements Under the Right to Try Act, Proposed Rule Dear Sir/Madam: The Biotechnology Innovation Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the opportunity to submit comments…
Patient-Take-Action
Become an Advocate for Biotechnology

Sign-up to join BIOAction, BIO's grassroots advocacy program. You will be notified about relevant policy issues where we need you to contact your lawmaker.

Join BIOAction
Placeholder Image
favorite Created with Sketch.
Coronavirus